Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. .
   PubMed Web of Science ®Google Scholar
• Guan LY, Lu Y. New developments in molecular targeted therapy of ovarian cancer. Discov Med. 2018;26(144):219–229.
   PubMed Web of Science ®Google Scholar
• Yan C, Wang J, Yang Y, et al. Molecular biomarker-guided anti-angiogenic targeted therapy for malignant glioma. J Cell Mol Med. 2019. DOI:10.1111/jcmm.14417
   Web of Science ®Google Scholar
• Ghafouri-Fard S, Shoorei H, Taheri M. Non-coding RNAs participate in the ischemia-reperfusion injury. Biomed Pharmacothe. 2020;129:110419.
   PubMed Web of Science ®Google Scholar
• Balamurali D, Stoll M. Non-Coding RNA Databases in Cardiovascular Research. Noncoding RNA. 2020;6(3). DOI:10.3390/ncrna6030035
   PubMed Web of Science ®Google Scholar
• Zhang C, Ren X, Zhang W, et al. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers. Bioengineered. 2020;11(1):1112–1123. .
   PubMed Web of Science ®Google Scholar
• Zheng S, Guo Y, Dai L, et al. Long intergenic noncoding RNA01134 accelerates hepatocellular carcinoma progression by sponging microRNA-4784 and downregulating structure specific recognition protein 1. Bioengineered. 2020;11(1):1016–1026.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui J, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Pichler M, Rodriguez-Aguayo C, Nam SY, et al. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020;69(10):1818–1831. .
   PubMed Web of Science ®Google Scholar
• Han H, Wang S, Meng J, et al. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2. Oncogene. 2020;39(42):6513–6528. .
   PubMed Web of Science ®Google Scholar
• Shuai Y, Ma Z, Liu W, et al. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. Mol Cancer. 2020;19(1):6. .
   PubMed Web of Science ®Google Scholar
• Li F, Chen Q, Xue H, et al. LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis. Cell Death Dis. 2020;11(10):894.
   PubMed Web of Science ®Google Scholar
• Chu J, Li H, Xing Y, et al. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. Biomed Pharmacothe. 2019;116:109029.
   PubMed Web of Science ®Google Scholar
• Ji D, Wang Y, Sun B, et al. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis. Biochem Biophys Res Commun. 2019;513(3):669–674.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Pan Y, Pan Y, et al. MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer. Cancer Manag Res. 2019;11:803–812.
   PubMed Web of Science ®Google Scholar
• Li J, Li Q, Li D, et al. Long non-coding RNA MNX1-AS1 promotes progression of triple negative breast cancer by enhancing phosphorylation of Stat3. Front Oncol. 2020;10:1108.
   PubMed Web of Science ®Google Scholar
• Zhang W, Huang L, Lu X, et al. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer. Bosn J Basic Med Sci. 2019;19(2):164–171.
   PubMed Web of Science ®Google Scholar
• Ma JX, Yang YL, He XY, et al. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A. Eur Rev Med Pharmacol Sci. 2019;23(11):4756–4762.
   PubMed Web of Science ®Google Scholar
• Wang J, Xing H, Nikzad AA, et al. Long noncoding RNA MNX1 antisense RNA 1 exerts oncogenic functions in bladder cancer by regulating miR-218-5p/RAB1A axis. J Pharmacol Exp Ther. 2020;372(3):237–247. .
   PubMed Web of Science ®Google Scholar
• Lv Y, Li H, Li F, et al. Long noncoding RNA MNX1-AS1 knockdown inhibits cell proliferation and migration in ovarian cancer. Cancer Biother Radiopharm. 2017;32(3):91–99.
   PubMed Web of Science ®Google Scholar
• Li AH, Zhang HH. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer. Eur Rev Med Pharmacol Sci. 2017;21(24):5618–5623.
   PubMed Web of Science ®Google Scholar
• Liu X, Yang Q, Yan J, et al. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway. J Cell Biochem. 2019;120(3):4268–4277.
   PubMed Web of Science ®Google Scholar
• Wu F, Zhong Y, Lang XB, et al. MNX1-AS1 accelerates the epithelial-mesenchymal transition in osteosarcoma cells by activating MNX1 as a functional oncogene. Eur Rev Med Pharmacol Sci. 2019;23(19):8194–8202.
   PubMed Web of Science ®Google Scholar
• Zhang YX, Cui HX, Liu L, et al. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1. Eur Rev Med Pharmacol Sci. 2019;23(14):6045–6052.
   PubMed Web of Science ®Google Scholar
• Zhang G, Fan E, Zhong Q, et al. Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer. Hum Genomics. 2019;13(1):36. .
   PubMed Web of Science ®Google Scholar
• Yang R, Wang L, Han M. MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma. J Cell Biochem. 2018;20(5):7222-7228.
   Web of Science ®Google Scholar
• Liu H, Han L, Liu Z, et al. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway. J Cell Physiol. 2019;234(8):13843–13850.
   PubMed Web of Science ®Google Scholar
• Liu G, Guo X, Zhang Y, et al. Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer. Onco Targets Ther. 2019;12:3129–3138.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang F, Zhang S. Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer. FEBS Open Bio. 2019;9(5):851–858.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xu Y, Wang J, et al. lncRNA MNX1-AS1 promotes glioblastoma progression through inhibition of miR-4443. Oncol Res. 2019;27(3):341–347.
   PubMed Web of Science ®Google Scholar
• Ye Y, Gu B, Wang Y, et al. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma. J Cell Biochem. 2019;120(4):6145–6153.
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(1):16.
   Google Scholar
• Andreas S. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   Google Scholar
• Ding J, Cao J, Chen Z, et al. The role of long intergenic noncoding RNA 00511 in malignant tumors: a meta-analysis, database validation and review. Bioengineered. 2020;11(1):812–823.
   PubMed Web of Science ®Google Scholar
• Gao X, Zhang L, Wei Y, et al. Prognostic value of XIAP level in patients with various cancers: a systematic review and meta-analysis. J Cancer. 2019;10(6):1528–1537. .
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed). 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Lin L, Chu H, Murad MH, et al. Empirical comparison of publication bias tests in meta-analysis. J Gen Intern Med. 2018;33(8):1260–1267. .
   PubMed Web of Science ®Google Scholar
• Ji D, Wang Y, Sun B, et al. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis. Biochem Biophys Res Commun. 2019. DOI:10.1016/j.bbrc.2019.04.012.
   Google Scholar
• Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16(4):195–203.
   PubMed Web of Science ®Google Scholar
• Lin L. Graphical augmentations to sample-size-based funnel plot in meta-analysis. Res Synth Methods. 2019;10(3):376–388.
   PubMed Web of Science ®Google Scholar
• Lin L. Hybrid test for publication bias in meta-analysis. Stat Methods Med Res. 2020;29(10):2881–2899.
   PubMed Web of Science ®Google Scholar
• Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785–794.
   PubMed Web of Science ®Google Scholar